Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Arkolamyl 10mg orodispersible tablets
040201060BDAAAT
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 15mg orodispersible tablets
040201060BDABAU
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 20mg orodispersible tablets
040201060BDADAV
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 5mg orodispersible tablets
040201060BDACAS
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.